31.08.2022 15:27:20

Baxter: FDA Approves New Novum IQ Syringe Infusion Pump With Dose IQ Safety Software

(RTTNews) - Baxter International Inc. (BAX) announced the FDA 510(k) clearance of its new Novum IQ syringe infusion pump with Dose IQ Safety Software. The company noted that its Novum IQ SYR has the capability to fully integrate with hospital electronic medical records through Baxter's IQ Enterprise Connectivity Suite.

The Novum IQ SYR features the company's Dose IQ Safety Software, a web-based, customizable drug library and dose error reduction system. The company said its Novum IQ SYR was designed to meet rigorous FDA guidance for infusion devices, including cybersecurity.

Analysen zu Baxter International Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Baxter International Inc. 28,25 1,64% Baxter International Inc.